Abstract
Hemangioblastoma (HB) is a benign vascular tumor that accounts for approximately 2% of intracranial neoplasms. HB of the lateral ventricles is extremely rare. Only a few reports are present in the literature. This article reports a 27-year-old male patient who arrived at our hospital because of a progressive headache lasting one month. The brain Magnetic Resonance Imaging (MRI) revealed a solid-cystic mass of 3.5×3.0 cm in size located in the left lateral ventricle, the surgery was performed by applying an interhemispheric approach to single frontal craniotomy with coronal incision to remove the tumor. The postoperative CT and MRI showed the successful complete removal of the tumor and a normal ventricle morphology. The differential diagnosis should be considered in case of intraventricular tumors including HB. Angiography should be performed prior to surgery when HB is suspected.
Introduction
Hemangioblastoma (HB) is a benign tumor that usually occurs in the posterior fossa of the central nervous system (CNS) and is more common in adults. This tumor is associated with von Hippel-Lindau disease (VHL) which is an autosomal dominantly inherited neoplastic disorder that demonstrates marked phenotypic variability and age-dependent penetrance. CNS HB occur in 60–80% of VHL patients and the remaining are sporadic cases (1). HB is responsible for approximately 2% of the intracranial tumors and 8% to 12% of the posterior fossa tumors (2, 3). Supratentorial HB is rare and only a few reports are available on the intraventricular location of a tumor, especially in the lateral ventricles (4, 5). In addition, only a few reported cases of solitary intraventricular HB of the lateral ventricles are available. Therefore, this work describes a case of HB located in the lateral ventricle based on the obtained imaging features and confirmed by pathology.
Case presentation
A 27-year-old male patient arrived at our hospital with a 1-month history of progressive headache. No neurologic deficits were found, and his medical history was not significant according to the physical examination. The brain computed tomography (CT) revealed the presence of a 3.5×3.0 cm hypo-isodense mass located in the left lateral ventricle. The magnetic resonance imaging (MRI) revealed a large solid-cystic mass extended from the left internal capsule to the left lateral ventricle. The ventricular septum was squeezed to the right. The mass was hypo-isointense on T1-weighted images and hyper-intense on T2-weighted images. The solid part of the mass was slightly heterogeneously enhanced after enhancement (Figure 1).
Figure 1
Our primary preoperative differential diagnosis according to the MRI features was an intraventricular subependymoma. Other potential diagnoses were glioma and central neurocytoma, while HB was not included in the differential diagnosis before surgery at the time of the initial diagnosis. The surgery was performed by realizing an interhemispheric approach to single frontal craniotomy with coronal incision to remove the tumor. When the tumor bulk was reached during surgery, a large mass was found, which was highly vascular and hemorrhagic (Figure 2). Finally, a ventricular drain was placed into the left lateral ventricle after removing all the visible parts of the tumor and after performing a meticulous intraventricular hemostasis. The postoperative brain CT scan showed the total removal of the tumor. The histopathological results of the mass indicated HB, which was not considered among our preoperative diagnoses (Figure 3).
Figure 2
Figure 3
After the surgery, the patient was in good health without neurological deficits and did not show any of the signs and symptoms previously reported. The follow-up after one month still revealed the absence of the tumor with normal ventricle morphology as shown by CT and MRI (Figure 4).
Figure 4
Discussion
Lateral ventricle tumors represent a small part of intracranial tumors, but they include many different biological types. The vast majority of the lateral ventricle tumors are benign with slow progression and are usually accidentally found because caused by symptoms of compression and hydrocephalus (6). However, the origin of the tumor and the age of the patients are somehow indicating a specific type of tumor according to published articles and shared experiences. Children are likely to develop choroid plexus papilloma, which occurs in the body and in the triangle area of the lateral ventricle. Hydrocephalus may be caused by this type of tumor, due to the excessive secretion of cerebrospinal fluid by the excessive stimulation of the choroid plexus (7). Meningiomas are usually found in the triangle area of the lateral ventricle in adults, with tumor calcification instead of cystic changes (8). Besides, ependymoma are CNS tumors and usually occurs in children (9). The treatment and prognosis of tumors vary greatly in line with their pathological nature. Therefore, a correct classification and evaluation of the lateral ventricle tumors are of utmost importance in guiding the surgical plan and long-term prognosis.
However, reports on HB in the lateral ventricle remain insufficient (10, 11). HB is a rare intracranial benign tumor originating from the remaining embryonic tissue composed of mesoderm cells, and it is a true vascular tumor. Microscopically, haemangioblastomas consist of large polygonal stromal cells enmeshed in a capillary network and stromal cells arise from mesoderm-derived embryologically arrested haemangioblasts (12). In 2016, WHO classified it as other types of tumors related to meninges (13). The incidence of HB is second only to medulloblastoma and astrocytoma, accounting for 1.1%-2.4% of the CNS tumors and 7%-12% of the posterior fossa tumors. This tumor is more common in young and middle-aged men, and the incidence rate in males and females is approximately 2:1 (14). It is mostly located in the infratentorial area, common in the cerebellum, but also in the brainstem and spinal cord. It is rarely observed in the supratentorial, and HB of the lateral ventricles is very rare (15). Only a few reports on lateral ventricular HB are available, as shown in Table 1. In our patient, HB was located in the left lateral ventricle, with imaging feature as cystic-solid type.
Table 1
| Author | Sex, age(years) | Signsand symptoms | Site | Preoperative imaging features | Diameter (cm) |
|---|---|---|---|---|---|
| Vecchi et al. (1935) (16) | Female, 80 | Incidental postmortem | N/A | N/A | N/A |
| Diehl et al. (1981) (17) | Male, 20 | Progressive visual loss, headache, bilateralpapilledema | Right temporal horn | CT scan,homogenous | 5 |
| Murakami et al. (1985) (18) | Female, 31 | Headache, gait disturbance, bilateralpapilledema | Trigone of rightlateral ventricle | CT scan,homogenous | N/A |
| Ho et al. (1990) (11) | Female, 44 | Headache | Trigone of rightlateral ventricle | MRI,homogenous | 3 |
| Lyo et al. (1992) (19) | Male, 36 | Headache, diplopia, right abducens nerve palsy,confusion | Left lateral ventriclewall | N/A | N/A |
| Prieto et al. (2005) (10) | Male, 37 | Confusion, cognitive deficit, dysphasia | Trigone of left lateral ventricle | MRI, homogenous | 3 |
| Jaggi et al. (2009) (20) | Male, 30 | Headache | Left lateral ventricle | MRI,homogenous | 3 |
| Takeuchi et al. (2011) (21) | Male, 33 | Headache | Right lateralventricle | MRI, solid-cystichomogenous | N/A |
| Al-Najar et al. (2013) (22) | Male, 70 | Headache, vomiting, dizziness, left facial palsy, left hemiparesis, intraventricularhemorrhage | Right occipital horn | MRI,heterogeneous | 3.3 |
| Anderson et al. (2014) (23) | Male, 24 | Vertigo, right arm weakness, transient right facial paresis and slurringof speech, headache | Midline and greater in left lateralventricle | MRI, solid-cystic with diffuseenhancement | N/A |
| Alireza Tabibkhooei et al. (2020) (24) | Male, 30 | Seizure, blurred vision, headache, bilateralpapilledema | Midline in bothlateral ventricle | MRI,heterogeneous | 5.5 |
| Present case (2022) | Male, 27 | headache | Left lateral ventricle | MRI, solid-cystic with diffuse enhancement | 3.5 |
Previous studies reporting HB cases.
N/A, not available.
The imaging manifestations of supratentorial and infratentorial HB are basically the same, and they are generally divided into three types: cystic-solid type, simple cystic type, and solid mass type. The supratentorial cystic-solid HB is mainly differentiated from low-grade astrocytoma, which shows mild enhancement and no peritumoral vascular shadows. However, cystic-solid HB generally has an evident enhancement, with vascular shadows around the tumor. It is also different from simple intracerebral cysts and arachnoid cysts. The signal of a simple cyst is similar to that of cerebrospinal fluid in each MRI sequence, with no vascular flow shadow around the cyst, while each sequence image of HB is higher than the cerebrospinal fluid signal shadow, indicating a potential vascular flow shadow around the cyst.
HB is closely related to Von Hippel-Lindau (VHL) disease. VHL is an autosomal dominant genetic disorder with 3 common types. Type I includes retinal and central nervous system HB (CNS-HB), renal cysts, renal carcinoma, and pancreatic cysts. Type II includes pheochromocytoma and pancreatic tumor of the islet cells, besides retinal HB and CNS-HB. Type III is less common and includes retinal HB, CNS-HB and pheochromocytoma (25). Generally, patients suffering from VHL are young and they genetically inherited it. Intracranial lesions can be multiple, accompanied by other diseases including retinal hemangioma and renal cysts. Therefore, children and adolescents should be screened for systemic lesions or VHL (26). In this patient, the possibility of VHL was excluded by abdominal B-ultrasound and fundus examination.
Surgery is currently the preferential option in the treatment of HB, although radiation and medication therapy are also considered. Preoperative embolization is of great use to reduce the risk of intraoperative bleeding due to the extremely rich blood supply, especially for solid tumors (27). Stereotactic radiotherapy provides good control of tumor growth and neurological protection but is not suitable for multiple lesions. Besides, inhibitors of vascular endothelial growth factors that block tumor angiogenesis may be considered as a novel treatment option (28).
Taken together, our report presented a rare case of HB in the lateral ventricle. The most relevant differential diagnosis of a mass in the lateral ventricle in this particular age group includes subependymoma, which is commonly associated with hydrocephalus and often presenting cystic components and calcifications but rarely presenting hemorrhage. Therefore, according to these characteristics (29), the disease in this patient was misdiagnosed as subependymoma before surgery. Angiography was not performed and consequently, our patient had severe intraoperative bleeding. Notably, VHL genetic screening is recommended for young patients and their family members. However, more cases should be described and research is in urgent need to provide a diagnostic basis and systematic treatment experience.
Conclusion
A patient with HB in the left lateral ventricles was described in this report. The MRI showed a regularly enhanced imaging in the solid part of the tumor. The main disadvantage of this case was the excessive intraoperative bleeding. Therefore, a preoperative angiography is recommended for the detection of large intraventricular cystic-solid masses. The differential diagnosis should be considered in case of intraventricular tumors including HB.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
Ethics statement
Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
RP, JS, and YZ performed the literature search; RP, JS, YX, and FB prepared the manuscript for submission; ZL contributed to the section on radiology; YZ was the lead clinician/surgeon and performed the operations described. All authors reviewed the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
HuntoonKShepardMJLukasRVMcCutcheonIEDanielsABAsthagiriAR. Hemangioblastoma diagnosis and surveillance in von hippel-lindau disease: a consensus statement. J Neurosurg (2021) 1:1–6. doi: 10.3171/2021.3.JNS204203
2
AmmermanJMLonserRRDambrosiaJButmanJAOldfieldEH. Long-term natural history of hemangioblastomas in patients with von hippel-lindau disease: implications for treatment. J Neurosurg (2006) 105(2):248–55. doi: 10.3171/jns.2006.105.2.248
3
LonserRRGlennGMWaltherMChewEYLibuttiSKLinehanWMet al. Von hippel-lindau disease. Lancet (London England) (2003) 361(9374):2059–67. doi: 10.1016/S0140-6736(03)13643-4
4
MillsSAOhMCRutkowskiMJSughrueMEBaraniIJParsaAT. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von hippel-lindau disease. Neuro-Oncology (2012) 14(8):1097–104. doi: 10.1093/neuonc/nos133
5
FurnessHSalfityLDevereuxJHallidayDHansonHRuddyDMet al. Investigation and management of apparently sporadic central nervous system haemangioblastoma for evidence of Von hippel-lindau disease. Genes (2021) 12(9):1414. doi: 10.3390/genes12091414
6
MorrisonGSobelDFKelleyWMNormanD. Intraventricular mass lesions. Radiology (1984) 153(2):435–42. doi: 10.1148/radiology.153.2.6333046
7
JaiswalAKJaiswalSSahuRNDasKBJainVKBehariS. Choroid plexus papilloma in children: Diagnostic and surgical considerations. J Pediatr Neurosci (2009) 4(1):10–6. doi: 10.4103/1817-1745.49100
8
NayarVVDeMonteFYoshorDBlacklockJBSawayaR. Surgical approaches to meningiomas of the lateral ventricles. Clin Neurol Neurosurg (2010) 112(5):400–5. doi: 10.1016/j.clineuro.2010.02.005
9
SpotoGPPressGAHesselinkJRSolomonM. Intracranial ependymoma and subependymoma: MR manifestations. AJR Am J Roentgenol (1990) 154(4):837–45. doi: 10.2214/ajr.154.4.2107685
10
PrietoRRodaJM. Hemangioblastoma of the lateral ventricle: case report and review of the literature. Neurocirugia (Asturias Spain) (2005) 16(1):58–62. doi: 10.1016/S1130-1473(05)70436-X
11
HoYSPletsCGoffinJDomR. Hemangioblastoma of the lateral ventricle. Surg Neurol (1990) 33(6):407–12. doi: 10.1016/0090-3019(90)90154-H
12
ParkDMZhuangZChenLSzerlipNMaricILiJet al. Von hippel-lindau disease-associated haemangioblastomas are derived from embryologic multipotent cells. PloS Med (2007) 4:e60. doi: 10.1371/journal.pmed.0040060
13
LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWKet al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (2016) 131(6):803–20. doi: 10.1007/s00401-016-1545-1
14
FerranteLAcquiMMastronardiLFortunaA. Supratentorial hemangioblastoma. report of a case and review of the literature. Zentralblatt fur Neurochirurgie (1988) 49(3):151–61.
15
BlackMLTienRDHesselinkJR. Third ventricular hemangioblastoma: MR appearance. AJNR Am J Neuroradiol (1991) 12(3):553.
16
VecchiBPatrassiG. Angioretriculoma del plessi corioidei, con” aree di Gamna. Schweiz Med Wochenschr (1935) 65:242–6.
17
DiehlPRSymonL. Supratentorial intraventricular hemangioblastoma: Case report and review of literature. Surg Neurol (1981) 15:435–43. doi: 10.1016/s0090-3019(81)80033-x.
18
MurakamiHToyaSOtaniMSatoSOhiraTTakenakaN. A case of concomitant posterior fossa and supratentorial hemangioblastomas. No Shinkei Geka (1985) 13:175–9.
19
LyoIUKimCJKwonYRhimSCLeeJKKwunBDet al. A Case of Hemangioblastoma in the Lateral Ventricle. J Korean Neurosurg Soc (1992) 21:195–200.
20
JaggiRSPremsagarICAbhishek. Hemangioblastoma of the lateral ventricle. Neurol India (2009) 57:677–9.
21
TakeuchiSTakasatoY. Supratentorial intraventricular hemangioblastomas. Acta Neurol Belg (2011) 111:353–6.
22
Al-NajarMAl-HadidyASalehAAl-TamimiAAl-DarawishAObeidatF. Sporadic lateral ventricular hemangioblastoma presenting with intraventricular and subarachnoid haemorrhage. Sultan Qaboos Univ Med J. (2013) 13:597–600. doi: 10.12816/0003324
23
AndersonIKumarRPatankarTTyagiA. Lateral ventricle haemangioblastoma: The role of perfusion scanning and embolisation in diagnosis and management. BMJ Case Rep (2014) 2014. doi: 1136/bcr-2014-205736
24
AlirezaTArashFAliR. A large solitary hemangioblastoma of the lateral ventricles: A case Report and literature review. Iran J Med Sci (2020) 45(1):67–72. doi: 10.30476/ijms.2019.81095
25
LatifFToryKGnarraJYaoMDuhFMOrcuttMLet al. Identification of the von hippel-lindau disease tumor suppressor gene. Sci (New York NY) (1993) 260(5112):1317–20. doi: 10.1126/science.8493574
26
MoshayediHOmofoyeOAYapEOyekunleTOSasaki-AdamsDMSolanderSY. Factors affecting the obliteration rate of intracranial aneurysms treated with a single pipeline embolization device. World Neurosurg (2017) 104:205–12. doi: 10.1016/j.wneu.2017.04.111
27
XiangJYuJChoiHDolan FoxJMSnyderKVLevyEIet al. Rupture resemblance score (RRS): toward risk stratification of unruptured intracranial aneurysms using hemodynamic-morphological discriminants. J Neurointerv Surg (2015) 7(7):490–5. doi: 10.1136/neurintsurg-2014-011218
28
WangTHuiXHZhouLXJuYRongHTZhangQ. [Expression of CXCR4 and VEGF in hemangioblastomas of the central nervous system and its relation to tumor angiogenesis]. Sichuan da xue xue bao Yi xue ban = J Sichuan Univ Med Sci edition (2010) 41(3):420–3. doi: 10.13464/j.scuxbyxb.2010.03.040
29
YinXDuanHYiZLuRLiCLiL. Clinical characteristics, surgical treatment, and risk factor analysis of postoperative functional outcome in patients with intracranial hemangioblastoma. World Neurosurg (2022) 161:e427–35. doi: 10.1016/j.wneu.2022.02.027
Summary
Keywords
hemangioblastoma, lateral ventricle, magnetic resonance imaging, case report, neurosurgery
Citation
Pan R, Shi J, Xu Y, Bo F, Luo Z and Zhang Y (2022) Hemangioblastoma in the lateral ventricle: An extremely rare case report. Front. Oncol. 12:948903. doi: 10.3389/fonc.2022.948903
Received
20 May 2022
Accepted
25 July 2022
Published
10 August 2022
Volume
12 - 2022
Edited by
Alberto Feletti, University of Verona, Italy
Reviewed by
Sakir Gultekin, University of Miami, United States; Mirza Pojskic, University Hospital of Giessen and Marburg, Germany
Updates
Copyright
© 2022 Pan, Shi, Xu, Bo, Luo and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yansong Zhang, 15805181640@163.com
†These authors have contributed equally to this work and share first authorship
This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.